Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood

By M. Sanderson S. C. Fox R. A. Robbins W. Losche P. Spangenberg S. Heptinstall H.  

Platelets, Vol. 9, Iss. 3-4, 1998-07 ,pp. : 245-250

Informa Healthcare

Access to resources Recommend Favorite

ATP does not affect fibrinogen binding to platelet GPIIbIIIa in systems free of signal transduction

By Liu Qingde   Sloan Stephen   Frojmovic Mony M.  

Platelets, Vol. 10, Iss. 6, 1999-12 ,pp. : 407-416

Informa Healthcare

Access to resources Recommend Favorite

Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells

By Oleksowicz L.   Mrowiec Z.   Schwartz E.   Khorshidi M.   Dutcher J.P.   Puszkin E.  

Thrombosis Research, Vol. 79, Iss. 3, 1995-08 ,pp. : 261-274

Elsevier

Access to resources Recommend Favorite

The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIb/IIIa antagonist

By Aoki T.   Cox D.   Senzaki K.   Seki J.   Tanaka A.   Takasugi H.   Motoyama Y.  

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 439-450

Elsevier

Access to resources Recommend Favorite

GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly

By A. May H. Ratan J. R. Glenn W. Losche P. Spangenberg S. Heptinstall J.  

Platelets, Vol. 9, Iss. 3-4, 1998-07 ,pp. : 227-232

Informa Healthcare

Access to resources Recommend Favorite